<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2023</year>
    <pub-dates>
     <date>2023-06-19</date>
    </pub-dates>
   </dates>
   <doi>10.3390/ijms24098021</doi>
   <abstract>Calvarial doughnut lesions (CDL) with bone fragility with or without spondylometaphyseal&#13;
dysplasia (MIM: #126550) is a rare autosomal dominant skeletal disorder characterized by low bone&#13;
mineral density, spinal and peripheral fractures, and specific sclerotic lesions of the cranial bones. In&#13;
the current classification of skeletal disorders, the disease is included in the group of bone fragility&#13;
disorders along with osteogenesis imperfecta. The disease is caused by pathogenic variants in the&#13;
SGMS2 gene, the protein product of which is sphingomyelin synthase 2, which primarily contributes&#13;
to sphingomyelin (SM) synthesis—the main lipid component of the plasma membrane essential for&#13;
bone mineralization. To date, 15 patients from eight families with CDL with bone fragility have been&#13;
described in the literature, and a recurrent variant c.148C&gt;T (p.Arg50Ter) in the SGMS2 gene has&#13;
been identified, which was found in patients from six families. We diagnosed the disease in 11 more&#13;
patients from three unrelated families, caused by the same heterozygous nonsense variant c.148C&gt;T&#13;
(p.Arg50Ter) in the SGMS2 gene. Our results show wide interfamilial and intrafamilial phenotypic&#13;
variability in patients with a detected recurrent variant in the SGMS2 gene, the presence of which&#13;
must be taken into consideration in the diagnosis of the disease. The primary analysis of this variant&#13;
will contribute to optimal molecular genetic diagnostics, which can reduce diagnostic costs and time.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/2774</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/2950</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
